To: | Teva Pharmaceutical Industries Ltd. (laurence.rickles@tevapharm.com) |
Subject: | U.S. Trademark Application Serial No. 90203458 - TEVA - N/A |
Sent: | February 10, 2021 11:54:47 AM |
Sent As: | ecom123@uspto.gov |
Attachments: |
United States Patent and Trademark Office (USPTO)
Office Action (Official Letter) About Applicant’s Trademark Application
U.S. Application Serial No. 90203458
Mark: TEVA
|
|
Correspondence Address: |
|
Applicant: Teva Pharmaceutical Industries Ltd.
|
|
Reference/Docket No. N/A
Correspondence Email Address: |
|
EXAMINER’S AMENDMENT
USPTO database searched; no conflicting marks found. The trademark examining attorney searched the USPTO database of registered and pending marks and found no conflicting marks that would bar registration under Trademark Act Section 2(d). 15 U.S.C. §1052(d); TMEP §704.02.
Application has been amended as shown below. As agreed to by applicant's attorney, Laurence Rickles, via a February 10, 2021 e-mail, the examining attorney has amended the application as shown below. Please notify the examining attorney immediately of any objections. TMEP §707. Otherwise, no response is required. Id. In addition, applicant is advised that amendments to the services are permitted only if they clarify or limit them; amendments that add to or broaden the scope of the services are not permitted. 37 C.F.R. §2.71(a).
The following translation statement is added to the record:
The English translation of the word "TEVA" in the mark is "nature".
See 37 C.F.R. §§2.32(a)(9), 2.61(b); TMEP §§809, 809.03.
If applicant has any questions regarding this Examiner's Amendment, please telephone the assigned examining attorney.
Matthew Howell
/Matthew Howell/
Examining Attorney
Trademark Law Office 123
(571)270-0992
matthew.howell@uspto.gov